Showing 94 news articles about Changing treatment

Filters Content type: Editors' picks Topic: Changing treatment

A change of HIV treatment may be necessary because of side-effects, the development of drug resistance, treatment not being fully effective or because of interactions between HIV drugs and other medications.

Changing treatment

HIV Regimen Switch May Contribute to Weight Gain

Editor's pick
Monthly Prescribing Reference
9 October 2017
Changing treatment

Terrence Higgins Trust and BHIVA advise on the use of generic HIV antiretroviral therapy

Editor's pick
Terrence Higgins Trust
16 August 2017
Changing treatment

HIV: A therapeutic advance for resource-limited settings

Editor's pick
Eurekalert Inf Dis
31 May 2017
Changing treatment

GlaxoSmithKline’s New Drug Challenges HIV Treatment Orthodoxy

Editor's pick
Wall Street Journal
20 December 2016
Changing treatment

Ask A Pharmacist: With a new tenofovir, should you switch to Descovy, Genvoya or Odefsey?

Editor's pick
BETA blog
20 September 2016
New & experimental HIV treatments

Frontier Biotech's Long-acting HIV-1 Fusion Inhibitor Albuvirtide Meets 48-Week Primary Objective: Interim Results of a Phase 3 Trial

Editor's pick
Frontier Biotech press release
7 June 2016
Health monitoring in resource-limited settings

HIV and drug resistance

Editor's pick
UNAIDS
9 February 2016
Viral load

Undetectable & Low-level HIV Viral Replication

Editor's pick
BETA blog
6 January 2016
Changing treatment

Study: Protease Inhibitor Monotherapy Does Not Limit Future Treatment Options

Editor's pick
BETA blog
10 December 2015
HIV treatment for children & young people

Study shows effectiveness of switching antiretroviral therapy for HIV-infected children

Editor's pick
Eurekalert Inf Dis
6 November 2015
Treatment guidelines

British HIV Association (BHIVA) 2015 Treatment Guidelines published

Editor's pick
BHIVA
26 September 2015
Changing treatment

New Phase IIIb/IV Data Show Switching to Once-Daily Triumeq® Maintains HIV Viral Suppression

Editor's pick
Viiv Healthcare press release
23 September 2015
Resistance

Pretreatment HIV drug resistance leads patients to switch to second-line ART

Editor's pick
Healio
11 August 2015
Treatment guidelines

Dolutegravir and Truimeq approved in England: London guidelines updated

Editor's pick
HIV i-Base
14 January 2015
Health monitoring in resource-limited settings

Sophisticated HIV diagnostics adapted for remote areas

Editor's pick
Science Daily
10 December 2014
Side effects

Effective treatments available for HIV patients not eligible for efavirenz regimens

Editor's pick
Science Daily
7 October 2014
Side effects

Switch From Efavirenz to Rilpivirine Quells CNS Toxicity, Improves Sleep

Editor's pick
NATAP
16 September 2014
Adherence

Switch from single-tablet regimen to 3 tablets works in Denmark

Editor's pick
International AIDS Society
10 July 2014
Treatment guidelines

New ARV prescribing guidelines for London (2014)

Editor's pick
HIV i-Base
1 July 2014
Changing treatment

Viral load rebounds in 35% of people using PI/r monotherapy: results of five-year PIVOT study

Editor's pick
HIV i-Base
10 March 2014
Changing treatment

U.S. FDA Approves Gilead’s Once-Daily Single Tablet HIV-1 Regimen Complera® for Patients Switching from a Stable Regimen

Editor's pick
Gilead press release
16 December 2013
Changing treatment

Once-daily raltegravir for 48 weeks as maintenance therapy in Paris

Editor's pick
NATAP
22 October 2013
Bone & joint problems

TDF/FTC-to-ABC/3TC switch maintains viral suppression, eases bone markers

Editor's pick
NATAP
19 September 2013
Changing treatment

Switching From Efavirenz to Rilpivirine Combo Quells CNS Side Effects

Editor's pick
NATAP
13 September 2013